Boston Scientific Corporation
US ˙ NYSE ˙ US1011371077

SecurityBSX / Boston Scientific Corporation
InstitutionGreenleaf Trust
Latest Disclosed Ownership24,165 shares
Latest Disclosed Value $ 1,516,354
Greenleaf Trust reports 5.00% decrease in ownership of BSX / Boston Scientific Corporation

On April 27, 2026 - Greenleaf Trust filed a 13F-HR form disclosing ownership of 24,165 shares of Boston Scientific Corporation (US:BSX) valued at $1,516,354 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 25,438 shares of Boston Scientific Corporation. This represents a change in shares of -5.00% during the quarter. The current value of the position is $1,180,460 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Boston Scientific Com 101137107 24,165 -1,273 -5.00 1,516 -37.48 0.0083
2026-01-21 2025-12-31 13F Boston Scientific Com 101137107 25,438 -1,157 -4.35 2,426 -6.59 0.0222
2025-10-22 2025-09-30 13F Boston Scientific Com 101137107 26,595 -175 -0.65 2,596 -9.70 0.0236
2025-07-17 2025-06-30 13F Boston Scientific Com 101137107 26,770 -1,488 -5.27 2,875 0.88 0.0254
2025-04-30 2025-03-31 13F Boston Scientific Com 101137107 28,258 1,665 6.26 2,851 20.00 0.0260
2025-01-24 2024-12-31 13F Boston Scientific COM 101137107 26,593 1,291 5.10 2,375 12.03 0.0216
2024-10-22 2024-09-30 13F Boston Scientific COM 101137107 25,302 -181 -0.71 2,120 8.05 0.0189
2024-07-22 2024-06-30 13F Boston Scientific COM 101137107 25,483 944 3.85 1,962 16.79 0.0186
2024-04-29 2024-03-31 13F Boston Scientific COM 101137107 24,539 -195 -0.79 1,681 17.56 0.0156
2024-01-31 2023-12-31 13F Boston Scientific COM 101137107 24,734 2,197 9.75 1,430 20.19 0.0153
2023-11-09 2023-09-30 13F Boston Scientific COM 101137107 22,537 495 2.25 1,190 -0.25 0.0137
2023-08-09 2023-06-30 13F Boston Scientific COM 101137107 22,042 -1,180 -5.08 1,192 2.67 0.0127
2023-05-11 2023-03-31 13F Boston Scientific COM 101137107 23,222 1,890 8.86 1,162 0.0131
2023-01-25 2022-12-31 13F Boston Scientific COM 101137107 21,332 2,261 11.86 1 -100.00 0.0125
2022-11-10 2022-09-30 13F Boston Scientific COM 101137107 19,071 2,316 13.82 739 18.43 0.0109
2022-08-12 2022-06-30 13F Boston Scientific COM 101137107 16,755 -1,294 -7.17 624 -21.90 0.0094
2022-04-27 2022-03-31 13F Boston Scientific COM 101137107 18,049 1,770 10.87 799 15.46 0.0095
2022-02-11 2021-12-31 13F Boston Scientific COM 101137107 16,279 1,584 10.78 692 8.46 0.0081
2021-11-12 2021-09-30 13F Boston Scientific COM 101137107 14,695 1,214 9.01 638 10.76 0.0078
2021-08-10 2021-06-30 13F Boston Scientific COM 101137107 13,481 649 5.06 576 16.13 0.0071
2021-04-30 2021-03-31 13F Boston Scientific COM 101137107 12,832 3,929 44.13 496 55.00 0.0066
2021-02-08 2020-12-31 13F Boston Scientific COM 101137107 8,903 -2,356 -20.93 320 -25.58 0.0043
2020-10-30 2020-09-30 13F Boston Scientific COM 101137107 11,259 2,205 24.35 430 35.22 0.0067
2020-08-12 2020-06-30 13F Boston Scientific COM 101137107 9,054 846 10.31 318 18.66 0.0056
2020-04-29 2020-03-31 13F Boston Scientific COM 101137107 8,208 -2,547 -23.68 268 -44.86 0.0053
2020-02-11 2019-12-31 13F Boston Scientific COM 101137107 10,755 -125 -1.15 486 9.71 0.0076
2019-11-08 2019-09-30 13F Boston Scientific COM 101137107 10,880 560 5.43 443 -0.23 0.0069
2019-07-24 2019-06-30 13F Boston Scientific COM 101137107 10,320 502 5.11 444 17.77 0.0070
2019-05-08 2019-03-31 13F Boston Scientific COM 101137107 9,818 733 8.07 377 17.45 0.0062
2019-02-07 2018-12-31 13F Boston Scientific COM 101137107 9,085 1,057 13.17 321 3.88 0.0063
2018-10-29 2018-09-30 13F Boston Scientific COM 101137107 8,028 8,028 309 0.0056
2018-04-30 2018-03-31 13F Boston Scientific COM 101137107 0 -392 -100.00 0 -100.00
2018-02-08 2017-12-31 13F Boston Scientific COM 101137107 392 -53 -11.91 10 -23.08 0.0002
2017-11-13 2017-09-30 13F Boston Scientific COM 101137107 445 445 13 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.